{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/182596190"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "announced that it has received regulatory approval under the Investment Canada Act.05 November 2013Endo Health Solutions agreed to buy Canadian drug company Paladin Labs for about $1.6 billion to expand in that country and emerging markets.The purchase, mostly through stock, values each Paladin Labs share at C$77.The deal gives Endo access to the Canadian market." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "currentpartnering.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/326350009"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/182596190"] } } }
